Arti Wongcha-um

Improved Eradication Rate of Standard Triple Therapy by Adding Bismuth and Probiotic Supplement for Helicobacter pylori Treatment in Thailand

Chanagune Srinarong, Sith Siramolpiwat, Arti Wongcha-um et al. · Asian Pacific Journal of Cancer Prevention · 2014 · 70 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area

Ratha‐Korn Vilaichone, Hatainuch Prapitpaiboon, Pornpen Gamnarai et al. · Asian Pacific Journal of Cancer Prevention · 2015 · 21 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial)

Natsuda Aumpan, Ratha‐Korn Vilaichone, Pongjarat Nunanan et al. · PLoS ONE · 2020 · 16 citations · Full text

Medicine, Oncology, Pathology +15

Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study

Panu Wetwittayakhlang, Khaled Karkout, Arti Wongcha-um et al. · Digestive and Liver Disease · 2023 · 14 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial)

Nuttapat Tungtrongchitr, Phubordee Bongkotvirawan, Sarita Ratana‐Amornpin et al. · Scientific Reports · 2024 · 13 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14